Fusion Pharmaceuticals Inc. Cash
Fusion Pharmaceuticals Inc. had Cash of $27.80 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2024-05-07
- 2024-03-31: Cash $27.80M.
- 2023-12-31: Cash $61.50M.
- 2023-09-30: Cash $26.80M.
- 2023-06-30: Cash $32.00M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2024-03-31 | $27.80M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $61.50M 10-Q · filed 2024-05-07 | |
| 2023-09-30 | $26.80M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $32.00M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $53.60M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $43.90M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $106.10M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $61.50M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $59.20M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $52.90M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $38.40M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $27.60M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $41.10M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $90.50M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $248.80M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $318.90M 10-Q · filed 2020-08-11 | |
| 2019-12-31 | $65.30M 10-K · filed 2021-03-25 | $74.00M 10-Q · filed 2020-08-11 |
| 2019-09-30 | $69.30M 10-Q · filed 2020-11-10 |